checkAd

     1509  0 Kommentare Three winners of 2019 Sandoz Healthcare Access Challenge (HACk) are announced at SXSW - Seite 2

    Andre Heeg, global Head of Digital at Sandoz, also speaking from Austin, added: "We believe Sandoz HACk is a key step towards realizing this vision, and we look forward greatly to working with all three winners to help bring their ideas to fruition. And there is no better place to celebrate the winner than SXSW: the global meeting point for innovative digital thinkers."

    Since arriving in Austin, Texas the three finalist teams (see below for details) attended a four-day "accelerator" event in parallel to SXSW. Working with Sandoz and industry experts, they discussed and re-assessed their ideas, with a view to creating practical, scalable solutions that can have a significant impact on people's lives. Finalists also attended SXSW sessions and networked with other participants and speakers to further stimulate development of their ideas.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Novartis AG!
    Short
    96,17€
    Basispreis
    0,65
    Ask
    × 14,66
    Hebel
    Long
    84,28€
    Basispreis
    0,66
    Ask
    × 13,99
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    All three finalists pitched their idea in person to a panel of judges, consisting of Sandoz and industry experts. The judging panel was led by Carol Lynch, President of Sandoz US and Head of Sandoz North America, and included Steffen Kurzawa, Global Head of Communications, Sandoz, John Frémont, Founder and Chief Strategy Officer of Hypergiant; Rich Maloy, Director at Established and Venture Partner at SpringTime Ventures; Jennifer Skjellum, Director of Programs at The Company Lab; and John W. Dankanich, Chief Technologist at NASA Marshall Space Flight Center. Judges assessed finalists based on criteria including the anticipated impact of their idea and the effective use of digital technologies.

    About the Sandoz HACk winners

    • ReguloraTM (Tim Rudolphi, US) - Irritable Bowel Syndrome (IBS) is a chronic and painful condition affecting approximately 10% of people worldwide. Recent clinical trials have shown that psychologically-focused treatments are an effective way to treat IBS, with over 50% of people enjoying significant relief from symptoms. ReguloraTM is in development as a prescription-only digital therapeutic based on Gut Directed Hypnotherapy. The mobile app connects patients with automated digital therapy sessions from the comfort of their own home, as well as offering daily practice routines and reports that track progress.   
    Seite 2 von 4


    Diskutieren Sie über die enthaltenen Werte


    GlobeNewswire
    0 Follower
    Autor folgen

    Verfasst von GlobeNewswire
    Three winners of 2019 Sandoz Healthcare Access Challenge (HACk) are announced at SXSW - Seite 2 Novartis International AG / Three winners of 2019 Sandoz Healthcare Access Challenge (HACk) are announced at SXSW . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Sandoz …

    Schreibe Deinen Kommentar

    Disclaimer